Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-23-000005

EVP Commercial sold 1,100 shares at $818.80 ($900,680)

  • EVP Commercial acquired 1,100 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

McCourt Marion · EVP Commercial

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-04-03 Exercise or conversion : show line 1 in the form 10b5-1 +1,100 $372.46 $409,706 21,903 D
2023-04-03 Sale : show line 2 in the form 10b5-1 −1,100 $818.80 $900,680 20,803 D
Open-market sales · 1,100 sh · avg $818.80 · $900,680

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-04-03 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −1,100 4,450 D
Loading xslF345X04/edgardoc.xml…